1616113-98-4 Usage
Description
Tert-butyl 2,7-dibromospiro[fluorene-9,4'-piperidine]-1'-carboxylate is a complex chemical compound featuring a spiropiperidine ring fused with a fluorene ring. It is characterized by the presence of two bromine atoms on the 2nd and 7th positions of the fluorene ring, along with a tert-butyl group and a carboxylate moiety. These structural elements suggest that it is a carboxylic acid derivative, which may influence its solubility and stability. While its exact uses and properties are not fully established, it may hold potential in the realms of organic synthesis or medicinal chemistry.
Uses
Used in Organic Synthesis:
Tert-butyl 2,7-dibromospiro[fluorene-9,4'-piperidine]-1'-carboxylate is used as an intermediate in organic synthesis for its unique structural features, which can be further modified or utilized in the creation of more complex organic molecules.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, tert-butyl 2,7-dibromospiro[fluorene-9,4'-piperidine]-1'-carboxylate may serve as a lead compound or a building block for the development of new pharmaceuticals, given its distinctive chemical structure and potential for modification.
Further research and investigation would be necessary to fully explore and confirm the applications and properties of tert-butyl 2,7-dibromospiro[fluorene-9,4'-piperidine]-1'-carboxylate in these or other fields.
Check Digit Verification of cas no
The CAS Registry Mumber 1616113-98-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,6,1,6,1,1 and 3 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1616113-98:
(9*1)+(8*6)+(7*1)+(6*6)+(5*1)+(4*1)+(3*3)+(2*9)+(1*8)=144
144 % 10 = 4
So 1616113-98-4 is a valid CAS Registry Number.
1616113-98-4Relevant articles and documents
MANNOSE DERIVATIVES FOR TREATING BACTERIAL INFECTIONS
-
Page/Page column 92-93, (2014/07/08)
The present invention relates to compounds useful for the treatment or prevention of bacteria infections. These compounds have formula (I). The invention also provides pharmaceutically acceptable compositions containing the compounds and methods of using the compositions in the treatment of bacteria infections. Finally, the invention provides processes for making compounds of the invention.
